5th Basic ECCO: EduCational COurse for Industry

Date       February 12, 2020
Time   10:00-17:00
Responsible Committee   ClinCom
Target audience   Corporate Members & Non-Corporate Members
Registration
  ECCO Membership 2020 NOT required
Please contact the ECCO Office at This email address is being protected from spambots. You need JavaScript enabled to view it. to register for this course
Registration fee:
Non-Corporate Members: 750 EUR (incl. 20% Austrian VAT)
ECCO Corporate Members: 500 EUR (incl. 20% Austrian VAT)

  • 5th Basic ECCO: EduCational COurse for Industry
    10:00-10:05 1: Welcome
    Laurent Peyrin-Biroulet, Vandoeuvre-lès-Nancy, France
    10:05-12:00 Session 1: Natural history and overall management
    Laurent Beaugerie, Paris, France
      10:05-10:25 2: What is IBD? Patient and physician perspective
    Walter Reinisch, Vienna, Austria
    Evelyn Groß, Graz, Austria
      10:25-10:40 3: What causes IBD?
    Timothy Raine, Cambridge, United Kingdom
      10:40-10:55 4: Diagnosis and assessing disease activity
    Peter Bossuyt, Bonheiden, Belgium
      10:55-11:10 5: Extraintestinal manifestations
    Gerhard Rogler, Zürich, Switzerland
      11:10-11:25 6: Risk factors for complicated outcome
    Shaji Sebastian, Hull, United Kingdom
      11:25-11:35 Question time
      11:35-12:00 7: Role of multidisciplinary team in IBD
    Christianne J. Buskens, Amsterdam, The Netherlands
    Peter M. Irving, London, United Kingdom
    Aileen Fraser, Bristol, United Kingdom
    12:00-13:00 Lunch break
    13:00-14:40 Session 2: IBD therapy
    Peter Bossuyt, Bonheiden, Belgium
      13:00-13:15 8: What is the role of 5-ASA and steroids?
    Uri Kopylov, Tel Aviv, Israel
      13:15-13:30 9: What is the role of immunomodulators?
    Javier Gisbert, Madrid, Spain
      13:30-13:45 10: What about biological therapy?
    Tariq Ahmad, Exeter, United Kingdom
      13:45-14:00 11: Small molecules and future treatment options
    Geert D’Haens, Amsterdam, The Netherlands
      14:00-14:15 12: How to choose between treatment modalities?
    Treatment target and individualised treatment options
    Severine Vermeire, Leuven, Belgium
      14:15-14:30 13: How to maximise safety? Cancer surveillance
    Laurent Beaugerie, Paris, France
      14:30-14:40 Question time
    14:40-15:00 Coffee break
    15:00-16:15 Session 3: Medical - surgical interface
    Shaji Sebastian, Hull, United Kingdom
      15:00-15:20 14: Perianal Crohn's Disease
    Willem Bemelman, Amsterdam, The Netherlands
    Krisztina B. Gecse, Amsterdam, The Netherlands
      15:20-15:40 15: Surgery and postoperative follow-up for luminal Crohn's Disease
    Antonino Spinelli, Milan, Italy
    Gionata Fiorino, Milan, Italy
      15:40-16:00 16: Surgery and pouch complications in Ulcerative Colitis
    Ailsa Hart, London, United Kingdom
    Janindra Warusavitarne, London, United Kingdom
      16:00-16:15 Question time
    16:15-17:00 Session 4: Future perspectives
    Krisztina B. Gecse, Amsterdam, The Netherlands
      16:15-16:35 17: The IBD quiz for industry
    Krisztina B. Gecse, Amsterdam, The Netherlands
      16:35-16:55 18: Where is the unmet need for patients with IBD?
    Julian Panes, Barcelona, Spain
    16:55-17:00 19: Closing remarks
    Krisztina B. Gecse, Amsterdam, The Netherlands